We are live on
!
Find out more
SC
Stralem & Co Portfolio holdings
AUM
$157M
1-Year Est. Return
4.29%
This Fund
S&P 500
This Quarter
Est. Return
+2.35%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$184M
AUM Growth
-$34.5M
(-16%)
Cap. Flow
-$38.5M
Cap. Flow
% of AUM
-20.92%
Top 10 Holdings %
Top 10 Hldgs %
35.09%
Holding
34
New
1
Increased
–
Reduced
32
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$5.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$6.61M |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.71M |
| 3 |
Visa
V
|
+$1.56M |
| 4 |
D.R. Horton
DHI
|
+$1.41M |
| 5 |
Broadcom
AVGO
|
+$1.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.28% |
| 2 | Technology | 16.97% |
| 3 | Financials | 12% |
| 4 | Communication Services | 9.97% |
| 5 | Utilities | 9.96% |
Similar funds
LI
BC
JT
SCM
HF
SMFS
CCM
CCM
Stralem & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Stralem & Co held 34 positions worth $184M, down 16% from $218M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Stralem & Co withdrew a net $38.5M in Q2 2019, closing 1 position and reducing 32 holdings. Its most notable exit was DuPont de Nemours, an estimated $6.61M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Financials.
Against the trend, Stralem & Co opened a new position in Dow Inc worth $5.05M.
- Stralem & Co's largest Q2 2019 buy was Dow Inc: 102,417 shares worth $5.05M.
- Stralem & Co's biggest Q2 2019 reduction was Meta Platforms (Facebook), cutting an estimated $1.71M.
- Stralem & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $6.61M.
- Stralem & Co's ten largest holdings make up 35% of its $184M portfolio in Q2 2019.
- Stralem & Co opened 1 new position and closed 1 in Q2 2019.
- Stralem & Co's portfolio value fell 16% quarter-over-quarter to $184M.
Based on Stralem & Co's 13F filing for Q2 2019, filed 16 Jul 2019.